{"id":"W3152013950","doi":"10.1016/j.eururo.2015.03.054","title":"Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Enzalutamide; Medicine; Abiraterone; Prostate cancer; Oncology; Internal medicine; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001245226,0.0007333045,0.001188997,0.0006998032,0.002403794,0.002369229,0.001115583,0.03862418,0.006675337],"category_scores_gemma":[0.01341935,0.0006389283,0.00131009,0.0006630661,0.001522659,0.001855028,0.001025987,0.02066342,0.003291729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004237233,"about_ca_system_score_gemma":0.002636304,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004321398,"about_ca_topic_score_gemma":0.007279819,"domain_scores_codex":[0.9987386,0.0003475297,0.0001993774,0.0001587794,0.0002780071,0.0002777524],"domain_scores_gemma":[0.9973125,0.001400586,0.0003798188,0.00008389822,0.0002848053,0.0005383004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002688151,0.0001209234,0.006048504,0.0001551641,0.00008552906,0.06875401,0.0002487805,0.0003820982,0.0006563657,0.006129317,0.8905755,0.02657505],"study_design_scores_gemma":[0.0007257702,0.0005530469,0.009848176,0.001339349,0.0003258212,0.1179416,0.001032526,0.004292411,0.001118668,0.02442727,0.838231,0.0001642984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.003342509,0.002868703,0.000107333,0.9725481,0.01394204,0.00001979278,0.0000793993,0.00002799592,0.007064137],"genre_scores_gemma":[0.05388065,0.004570149,0.0003709936,0.7928779,0.1276365,0.00005546782,0.0001309161,0.00004456353,0.02043297],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.03862418,"threshold_uncertainty_score":0.03074342,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03451015444388993,"score_gpt":0.3076103422591034,"score_spread":0.2731001878152135,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}